Calcineurin inhibitors treatment in kidney transplant recipients is frequently associated with hyperkalemia, acidosis and hypertension but not with increased expression or phosphorylation of the sodium chloride cotransporter.
- DOI
- 10.3389/fneph.2026.1917605
- Published
- 2026
- Container
- Frontiers in nephrology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fneph.2026.1917605,
title = {Calcineurin inhibitors treatment in kidney transplant recipients is frequently associated with hyperkalemia, acidosis and hypertension but not with increased expression or phosphorylation of the sodium chloride cotransporter.},
author = {Di Ascia L and Baraka-Vidot J and Ferdynus C and Duong JP and Bairras Martin C and Merville P and Couzi L and Eladari D and Chambrey R},
year = {2026},
journal = {Frontiers in nephrology},
doi = {10.3389/fneph.2026.1917605},
url = {https://doi.org/10.3389/fneph.2026.1917605}
}RIS
TY - JOUR TI - Calcineurin inhibitors treatment in kidney transplant recipients is frequently associated with hyperkalemia, acidosis and hypertension but not with increased expression or phosphorylation of the sodium chloride cotransporter. AU - Di Ascia L AU - Baraka-Vidot J AU - Ferdynus C AU - Duong JP AU - Bairras Martin C AU - Merville P AU - Couzi L AU - Eladari D AU - Chambrey R PY - 2026 JO - Frontiers in nephrology DO - 10.3389/fneph.2026.1917605 UR - https://doi.org/10.3389/fneph.2026.1917605 ER -
APA
L, D. A., J, B., C, F., JP, D., C, B. M., P, M., L, C., D, E., & R, C. (2026). Calcineurin inhibitors treatment in kidney transplant recipients is frequently associated with hyperkalemia, acidosis and hypertension but not with increased expression or phosphorylation of the sodium chloride cotransporter.. Frontiers in nephrology. https://doi.org/10.3389/fneph.2026.1917605
Source records
- pubmed · retrieved 2026-11-10T11:03:52.780Z